Cite

HARVARD Citation

    de Weger, V. et al. (2017). A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir. European journal of cancer. pp. 217-225. [Online]. 
  
Back to record